BioSpace News Archive

Business

Sigilon Therapeutics Appoints Eric Shaff to Board of Directors

Sigilon today announced the appointment of Eric Shaff, CFO of Seres, to the Sigilon board of directors.

November 1, 2017

·

2 min read

Business

RXi Pharmaceuticals to Webcast Third Quarter 2017 Financial Results on Wednesday, November 8, 2017

RXi Pharma today announced that it will report its financial results for the third quarter ended September 30, 2017, and provide a business update on Wednesday, November 8, 2017 after the close of the U.S. financial markets.

November 1, 2017

·

3 min read

Pharm Country

CytoSorbents Awarded Approximately $1M in Phase II SBIR Funding to Optimize New Treatment Approaches for Severe Hyperkalemia

This award, valued at a total of $999,871 over 29 months, follows the successful completion of the previously announced $150,000 Phase I SBIR for the program.

November 1, 2017

·

6 min read

Drug Development

FDA Grants Rare Pediatric Disease Designation to ArQule’s Miransertib (ARQ 092) for the Treatment of Proteus Syndrome

Miransertib is an orally available, selective pan-AKT inhibitor.

November 1, 2017

·

8 min read

Genetown

FDA Grants Fast Track Designation to Visterra’s VIS410 for Treatment of Hospitalized Patients with Influenza A

Visterra is a clinical-stage biotechnology company that uses its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines against such targets that are not adequately addressed with conventional approaches.

November 1, 2017

·

4 min read

GSK Study Demonstrates Superiority of Anoro Ellipta to Stiolto Respimat in Improving Lung Function in Chronic Obstructive Pulmonary Disease

This endpoint was met, and furthermore UMEC/VI demonstrated superiority to TIO/OLO.

November 1, 2017

·

12 min read

Business

Bristol-Myers Squibb, BioLabs Announce Founding Sponsorship in Support of Promising Biotech Companies in New York

As part of the agreement, for each year of active sponsorship, Bristol-Myers Squibb can nominate up to three innovative life-sciences and biotech startup companies per year to take up residence in BioLabs’ facilities at 180 Varick Street in Manhattan.

November 1, 2017

·

4 min read

Business

Veeva Announces Partner Approach for Best-in-Class Randomization and Trial Supply Management

Veeva is bringing together a modern EDC cloud application with best-in-class randomization and trial supply software to help the life sciences industry improve data quality and accelerate execution when managing complex clinical trials.

November 1, 2017

·

5 min read

Business

Owens & Minor Reports 3rd Quarter 2017 Financial Results

Consolidated operating earnings for the third quarter of 2017 were $29.7 million, compared to $53.6 million in last year’s third quarter.

November 1, 2017

·

22 min read

BioCapital

Owens & Minor Approves 4th Quarter 2017 Dividend

The cash dividend is payable on December 29, 2017, to shareholders of record as of December 15, 2017.

November 1, 2017

·

1 min read